share_log

Aoshikang Technology (SZSE:002913) Sheds CN¥413m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Three Years

Aoshikang Technology (SZSE:002913) Sheds CN¥413m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Three Years

奥士康科技(SZSE:002913)脱落了41300万元人民币,公司收入和投资者回报在过去三年一直呈下降趋势
Simply Wall St ·  11/29 08:18

For many investors, the main point of stock picking is to generate higher returns than the overall market. But in any portfolio, there are likely to be some stocks that fall short of that benchmark. Unfortunately, that's been the case for longer term Aoshikang Technology Co., Ltd. (SZSE:002913) shareholders, since the share price is down 45% in the last three years, falling well short of the market decline of around 15%. And more recent buyers are having a tough time too, with a drop of 22% in the last year. Unfortunately the share price momentum is still quite negative, with prices down 9.5% in thirty days.

对于许多投资者来说,选择股票的主要目标是产生比整体市场更高的回报。但是在任何投资组合中,都可能有一些股票未能达到这一基准。不幸的是,长期持有奥士康科技有限公司(SZSE:002913)股票的股东们就是这种情况,因为过去三年股价下跌了45%,远低于市场约15%的跌幅。而且,最近买入的投资者也面临着困难,过去一年股价下跌了22%。不幸的是,股价动能仍然是非常负面的,三十天内价格下跌了9.5%。

Given the past week has been tough on shareholders, let's investigate the fundamentals and see what we can learn.

考虑到过去一周对股东来说是艰难的,让我们调查一下基本面并看看我们能学到什么。

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

尽管市场是一个强大的定价机制,股价不仅反映了基本业务表现,还反映了投资者的情绪。通过比较每股收益(EPS)和股价变化,并随时间推移这样做,我们可以了解股东对公司的态度如何随时间变化。

During the three years that the share price fell, Aoshikang Technology's earnings per share (EPS) dropped by 12% each year. This reduction in EPS is slower than the 18% annual reduction in the share price. So it seems the market was too confident about the business, in the past.

在股价下跌的三年中,奥士康科技的每股收益(EPS)每年下降了12%。每股收益的下降速度慢于股价每年18%的跌幅。所以过去市场对该业务似乎过于自信。

The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).

下图显示了EPS随时间的变化情况(如果您单击该图像,则可以查看更多详细信息)。

big
SZSE:002913 Earnings Per Share Growth November 29th 2024
深交所:002913 每股收益增长 2024年11月29日

This free interactive report on Aoshikang Technology's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

这份关于奥士康科技的收益、营业收入和现金流的免费互动报告是一个很好的开始,如果您想进一步研究这只股票。

What About The Total Shareholder Return (TSR)?

那么,股东总回报(TSR)呢?

We'd be remiss not to mention the difference between Aoshikang Technology's total shareholder return (TSR) and its share price return. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Its history of dividend payouts mean that Aoshikang Technology's TSR, which was a 42% drop over the last 3 years, was not as bad as the share price return.

我们不能不提及奥士康科技的总股东回报率(TSR)与其股价回报之间的差异。TSR是一个回报计算,考虑了现金分红的价值(假设所收到的任何分红都是再投资的)以及任何折扣融资和分拆所计算的价值。其分红支付的历史意味着,奥士康科技的TSR在过去三年中下降了42%,但并没有股价回报那么糟糕。

A Different Perspective

另一种看法

While the broader market gained around 6.8% in the last year, Aoshikang Technology shareholders lost 21%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 1.0% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. Before forming an opinion on Aoshikang Technology you might want to consider these 3 valuation metrics.

虽然整体市场在过去一年中增长了大约6.8%,但奥士康科技的股东却损失了21%。然而,请记住,即使是最好的股票,有时在十二个月的时间里也会表现不佳。不幸的是,去年的表现可能表明存在未解决的挑战,因为其表现比过去五年年化损失1.0%的情况还要糟糕。我们意识到巴伦·罗斯柴尔德曾说过投资者应该在街上有血时"买入",但我们警告说,投资者首先应该确保他们购买的是高质量的业务。在对奥士康科技形成意见之前,您可能想考虑这三个估值指标。

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: many of them are unnoticed AND have attractive valuation).

如果您喜欢与管理层一起购买股票,那么您可能会喜欢这个公司的免费列表。 (提示:其中许多公司不为人注意且具有吸引力的估值。)

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文中引用的市场回报反映了目前在中国交易所上市的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发